A detailed history of Impac Tfolio, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Impac Tfolio, LLC holds 1,316 shares of ABBV stock, worth $236,880. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,316
Previous 1,316 -0.0%
Holding current value
$236,880
Previous $225,000 15.11%
% of portfolio
0.13%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 02, 2024

BUY
$137.6 - $154.97 $181,081 - $203,940
1,316 New
1,316 $203,000
Q4 2022

Jan 03, 2023

BUY
$138.31 - $165.87 $182,015 - $218,284
1,316 New
1,316 $213,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Impac Tfolio, LLC Portfolio

Follow Impac Tfolio, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impac Tfolio, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Impac Tfolio, LLC with notifications on news.